A booster dose of the candidate malaria vaccine has maintained a high level of protection against the disease and continued to meet the World Health Organisation’s (WHO) specified percent efficacy goal, researchers have disclosed.
Researchers from the University of Oxford and their partners las
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
